From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer [Erratum]

Rodallec A, Sicard G, Giacometti S, et al. Int J Nano. 2018;13:6677–6688.

On page 6684, Table 1 should be as follows:

Table 1.

Treatment	Beginning of treatment (×1010)	End of treatment (×1010)
MDA-MB-453 bearing mice
Control	1.15	1.73
Liposome + free trastuzumab	0.877	2.53
Immunoliposome	1.70	1.72
MDA-MB-231 bearing mice
Control	1.19	5.96
Liposome + free trastuzumab	1.49	3.88
Immunoliposome	1.38	3.44